AKAO: Achaogen Inc
AKAO is recent drug trial news EP. Since then it had a secondary offering at 13.50. Now set for a breakout. Target 20
GS: Goldman Sachs
GS: After recent up move is consolidating for possible next up leg.
DFS: Discovey Financial Services
EPE: Recent breakout on high volume consolidating for next up leg
Other Anticipation candidates:
AKAO
GS
DFS
CWEI
EGRX
REN
MC
WLB
CNAT
IVC
HMST
VRTU
NXST
CECE
TDY
PLAY
SMTC
NSM
VIRT
CORE
ZLTQ
UIS
RHP
PEGA
BNCN
PAG
ANET
LOPE
WCG
HMN
AMN
SFBS
TCBI
ATW
KTOS
NGHC
TRUE
SIVB
FNGN
IBOC
TRMK
PFS
AAP
UCBI
FFIV
EPE
PVTB
BPOP
BRO
STL
CIEN
CSRA
TRN
TCB
NTAP
MSI
ZION
NTRS
MDR
P
FHN
LNC
HES
CBG
DE
LUK
APC
LUV
DAL
HBAN
KEY
RF
KBAL
ERF
4 comments:
Hi Pradeep
Been watching AKAO -- got about 7% run today
when do you sell?
Target is 20 on it
How to get the target value?
It is stock specific based on sector, float, price, past action.
Post a Comment